A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Ascentage Pharma Group Inc.
BerGenBio ASA
UTC Therapeutics Inc.
Centre Hospitalier Universitaire Vaudois
Seagen Inc.
Quadriga Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Chinese PLA General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)